We have compared the analgesic efficacy of the racemic mixture and the stereoisomer (S;) of the NMDA antagonist ketamine. In a double-blind, three-way crossover, placebo-controlled study, we assessed the following: pain evoked by small/large area pressure stimuli, pain detection threshold and pain ratings to small/large area of heat stimuli, pain detection threshold and pain rating to heat stimuli of brief/long duration, summation pain threshold and pain ratings to repeated heat/ electrical stimuli, side effects and reaction time. Plasma concentrations of 350 ng ml 91 for ketamine (racemic) and 180 ng ml 91 for ketamine (S;) were tried. We found that ketamine (racemic) prolonged the reaction time more than ketamine (S;). Both drugs affected pain caused by repeated stimuli or stimuli of long duration equally or more than a single stimulus of short duration. They also affected pain evoked from large areas equally or more than pain evoked from small areas. The (S;)-isomer was approximately twice as potent as the racemic mixture of ketamine in inhibiting central summation. (Br.
Several studies have indicated that anaesthetic agents are less effective in blocking pain caused by repeated/prolonged stimuli than pain caused by a single stimulus, and less effective in blocking stimuli covering large areas than stimuli covering small areas. [1] [2] [3] [4] [5] Increased pain caused by repetition is termed temporal summation and increased pain as a result of activation of a large area is termed spatial summation.
Wind-up (increased and prolonged firing after repeated stimulation) in animal dorsal horn neurones [6] [7] [8] is probably the mechanism underlying temporal summation in humans. The mechanism behind spatial summation is less clear but is presumably a result of convergence on central neurones. Techniques to investigate wind-up are needed to assess the effect of different anaesthetic drugs on this mechanism in humans. Psychophysical and electrophysiological techniques have been established to assess temporal [9] [10] [11] and spatial 1 2 
summation in humans.
Animal experiments have shown that NMDA antagonists inhibit wind-up. 12 13 In human studies, NMDA antagonists (ketamine, dextromethorphan) were found to attenuate temporal summation. 10 14 Unfortunately, few NMDA antagonists are available for human use and the existing drugs have severe psychomimetic side effects. Commercially available ketamine is a racemic mixture. In animal experiments the stereoisomer, ketamine (S;), has proved to be 2-3 times more potent but less psychoactive than the (R9)-isomer. 15 In a human study the (S;)-isomer was four times more potent than the (R9)-isomer for management of postoperative pain. 16 Therefore, the (S;)-isomer offers clinically useful advantages if an equipotential dose causes less side effects than the racemic mixture.
The aim of this double-blind, placebo-controlled human study was to use psychophysical techniques to determine the analgesic potency of ketamine (racemic) and ketamine (S;) on temporal and spatial summation and to compare potency and side effects.
Subjects and methods
We studied 12 paid, healthy students (mean age 27.1 (range 23-41) yr). Mean weight was 69.8 kg (range 58-86 kg). Informed consent according to the Helsinki Declaration was obtained and the study was approved by the Regional Scientific Ethics Committee, Bern.
I.v. infusion of NaCl-glucose was started before testing. Pulse oximetry 2 O ( p ), S ECG and non-invasive arterial pressure were monitored during the study. Skin temperature at the lateral aspect of the forearm was measured by a medical precision thermometer (Therm 3480-6, Holzkirchen, Deutschland). Mean reaction time to five 1000-Hz tone stimuli was determined.
STIMULATION AND THRESHOLDS

Heat stimulation
The heat stimulator had a circular contact surface with a diameter of 20 mm (314 mm   2 ). This surface consisted of a thin copper foil placed on top of a thermofoil (Minco Products, Inc.), being a resistive heating element in principle ( fig. 1 ). As the mass of the heating element was low, rapid increases in temperature were obtained (30ЊC s
91
). The thermofoil was maintained at a constant baseline temperature (35ЊC) by adjusting the current passing through the element. Temperature was calibrated by the medical precision thermometer. To obtain active cooling of the skin after each stimulation, a relatively large aluminium block was placed behind the thermofoil. This block was maintained at a constant temperature of 10ЊC by a Peltier device and cooling water. This resulted in a skin cooling rate of up to 15ЊC s
. Five identical heat stimulators were controlled individually and the areas activated by one, two, three, four and five thermodes were 314 mm 2   ,  628 mm   2   , 942 mm   2   , 1256 mm  2 and 1570 mm   2 , respectively. The circular thermodes were placed on a line with a centre-to-centre distance of 50 mm. Heat pulses were delivered to the lateral aspect of the forearm without preparing the skin in any way. The inter-stimulus time was distributed randomly between 15 and 20 s.
Spatial summation
This stimulation procedure investigated if the drugs affected small and large areas in a similar way. the thermal pain threshold to one and five thermodes  (314 and 1570 mm   2 , respectively). The heat pain detection threshold was determined as the point where thermal sensation became painful. Peak temperature was increased automatically in steps of 0.5ЊC until the threshold was reached. The stimulus was increased by 8ЊC s 91 and maintained at the peak temperature for 2 s.
Spatial summation was investigated by detection of
Temporal summation
This stimulation procedure determined if the drugs affected single and repeated stimuli in the same way, and short and long duration stimuli in a similar way. Temporal summation was investigated using a single thermode (314 mm 2 ) and five pulses delivered at 0.66 Hz (rise time 30ЊC s
91
). The heat summation pain threshold was determined as the temperature at which the subject reported the pain to increase during the course of five stimuli. 11 Temperature was increased automatically in steps of 0.5ЊC until the summation threshold was reached.
Another method of investigating temporal summation was to change the duration of the heat pulse. Volunteers were stimulated with one and five thermodes at a supra-threshold temperature of 50ЊC in two ways: (1) 50ЊC of one thermode was reached at 8ЊC s 91 and then immediately returned to baseline. Pain intensity was rated on a VAS scale; (2) 50ЊC of one and five thermodes was reached at 8ЊC s 91 and maintained for 2 s and then returned to baseline. Pain intensity was rated on a VAS scale.
Electrical stimulation
This stimulation procedure examined if the drugs affected single and repeated stimuli in a similar manner. A constant current, computer-controlled stimulator (Aalborg University, Denmark) was used for percutaneous electrical stimulation of the sural nerve using a electrode with two silver-silver chloride electrodes separated by 20 mm (13L20, Dantec, Denmark). Five constant current 1-ms pulses supplied rectangularly at 200 Hz were defined as a "single stimulus". When this single stimulus was repeated five times at 2 Hz, it was defined as "repeated stimuli". The electrical summation pain threshold to repeated stimuli was determined as the point at which the subject felt an increasing sensation during the five stimuli 11 eventually resulting in pain. The intensity was increased in steps of 1 mA until the summation threshold was reached. At least 10 s elapsed between individual stimuli. The VAS rating to 1.2 times the baseline summation pain threshold was determined.
Pressure stimulation
This stimulation procedure investigated if the drugs affected small and large areas in a similar way. Pressure was applied using an electronic pressure algometer (Somedic AB, Stockholm, Sweden). Pressure pain detection and tolerance thresholds were determined using two different probe areas Figure 1 Schematic drawing of the thermal stimulator used in this study. The heat foil is maintained at a baseline temperature of, for example 35 ЊC (T1). The heat foil is glued (by thermal conductive glue) to an aluminium block maintained at a temperature of 10 ЊC (T2). This controlled cooling temperature is obtained by a Peltier device which is again cooled by water.
(6.0 mm and 10.8 mm diameter, 28 mm 2 and 92 mm 2 , respectively) applied at the second and third finger pulps of the left and right hand. Pressure was increased with a fixed rate of 50 kPa s 91 corresponding to 1.4 N s 91 and 4.6 N s 91 for the small and large areas, respectively. Ten to 15 s elapsed between stimuli.
MEDICATION
Volunteers received ketamine (racemic), ketamine (S;) or placebo (saline) in a randomized, doubleblind, crossover design. Ketamine (racemic and S;) was administered by a target-controlled infusion system. This consisted of a computer connected to a Harvard 22 (Harvard Apparatus, South Natick, MA, USA) infusion pump with a serial interface. The pharmacokinetic variables for ketamine reported by Domino and co-workers 17 were programmed into the software Stanpump (Stanpump is available at no charge from the author, Steven L. Shafer, MD, Anesthesiology Service (112A), Pavamc, 3801 Miranda Ave, Palo Alto, CA 94304, or from the WWW at URL: http:@pkpd.icon. palo-alto.med.va.gov.). Stanpump attempts to maintain a constant plasma concentration by simulation. The programmed pump variables do not consider any stereoselective differences in ketamine pharmacokinetics. Pseudo-steady-state concentrations of 350 ng ml 91 and 180 ng ml 91 were targeted for racemic and ketamine (S;), respectively.
GENERAL CONDITION AND SIDE EFFECTS
Before the tests, subjects were asked if they felt calm/agitated (0 : very calm, 10 : very agitated), well/bad (0 : very well, 10 : very bad), and had side effects such as dreams (0 : no dreams, 10 : dreams all the time), and if dreams (0 : very pleasant dreams, 10 : very unpleasant dreams), or hallucinations (0 : none, 10 : much). The general condition and side effects were rated on a 10-cm electronic rating scale. Dreams were explained as experiences having a connection to reality and hallucinations without connection to reality. After the baseline series the target-controlled infusion was started and equilibration for 15 min was allowed to ensure constant plasma and CNS concentrations ( fig. 2 ). A test series was then performed. Thereafter, the infusion was stopped, and a final test series was performed 60 min after the infusion was terminated. At this last test series the predicted plasma concentration (Stanpump) declined to only 6-8 ng ml 91 for racemic ketamine and 3-4 ng ml 91 for ketamine S;.
STATISTICAL ANALYSIS
For each measurement (temperature, heat, pain threshold, etc.), the variance between drugs (racemic ketamine, (S;)-ketamine, placebo) and the conditions (before, during and after infusion) were tested using a two-factor ANOVA for repeated measures. In the event of interaction between drug and condition, multiple pairwise comparisons of the measures (e.g. heat, pain threshold before vs after ketamine) were performed with the StudentNewman-Keuls method for corrections of repeated measures. In cases where data for different measurements (e.g. small and large stimulation areas) were pooled, Student's t test was used for comparison. P : 0.05 was regarded as significant.
Results
GENERAL CONDITION AND SIDE EFFECTS
One volunteer was able to participate in only two of the sessions and was withdrawn from the rest of the experiment. During the three sessions, no differences in "general feelings" (table 1) were reported before, during or after infusion. The amounts of infused ketamine (racemic) and ketamine (S;) were 59.75 (5.29) mg and 29.22 (2.55) mg, respectively. The reaction times (table 2) to auditory stimuli were increased (P : 0.001-0.002) by approximately 100 and 50 ms after infusion of ketamine (racemic) and ketamine (S;), respectively. These changes were significant (P : 0.001-0.003) compared with placebo. Ketamine (racemic) showed a significantly The approximately 0.1-s increase in reaction time for ketamine affected the thresholds only marginally. The slowing in reaction time caused maximally a 5-kPa increase in pressure thresholds, and 0.2ЊC and 0.8ЊC increases in thresholds to slow and fast temperature rise times. As skin temperature at the same time was decreased by approximately 1ЊC, the influence was limited. PRESSURE PAIN DETECTION AND TOLERANCE   THRESHOLDS (TABLE 3) For the small probe (28 mm 2 ), increases (P : 0.006-0.004) in pain detection and pain tolerance thresholds were obtained after infusion of ketamine (racemic) (374 and 164 kPa) and ketamine (S;) (315 and 207 kPa).
For the large probe (92 mm 2 ), increases (P : 0.002-0.008) in pain detection and pain tolerance thresholds were obtained after infusion of ketamine (racemic) (244 and 129 kPa) and ketamine (S;) (146 and 104 kPa). A difference (P : 0.002-0.03) from placebo was found for all tolerance thresholds except for the ketamine (S;) tolerance threshold. An increase (P : 0.01) in the pain detection threshold was found after infusion of ketamine (racemic) compared with infusion of ketamine (S;).
The active drugs affected the large area to the same degree as the small area. When threshold determinations for the small and large probes were pooled, the pain detection thresholds increased (P : 0.004) more than the tolerance thresholds for both drugs.
HEAT PAIN DETECTION THRESHOLDS TO ONE AND FIVE THERMODES (TABLE 4)
For one thermode (314 mm 2 ), an increase in heat pain threshold (2.7ЊC) was obtained after infusion of ketamine (racemic) (P : 0.001) and ketamine (S;) (P : 0.004, 2.1ЊC). These changes were significant compared with placebo (P : 0.002, P : 0.003). For simultaneous activation of five thermodes (1570 mm 2 ), increases (P : 0.001-0.002) in the thresholds after ketamine (racemic) (3.6ЊC) and ketamine (S;) (2.4ЊC) were found compared with baseline and placebo, respectively. No differences were found between threshold changes for one and five thermodes. When threshold determinations for both drugs were pooled, a trend (P 9 0.08) towards a larger increase in the five probe threshold than in the one probe threshold was found. Infusion of ketamine (racemic) increased significantly the threshold to five probes (P : 0.002) more than ketamine (S;).
VAS RATING TO ONE AND FIVE THERMODES (TABLE 4)
A decrease in the VAS ratings to one thermode (50ЊC, 8ЊC s 91 , 2 s duration) was found after infusion of ketamine (racemic) and ketamine (S;) compared with baseline (P : 0.001-0.002) and placebo (P : 0.01-0.02), showing no difference between drugs.
A decrease in VAS ratings to five thermodes (50ЊC, 8ЊC s 91 , 2 s duration) was found after infusion of ketamine (racemic) and ketamine (S;) compared with baseline (P : 0.001-0.003) and placebo (P : 0.001-0.006), with no difference between drugs. There were no differences between VAS rating changes for one and five thermodes. If the heat pain thresholds and the VAS ratings to one and five thermodes for the two drugs were pooled statistically, measurements related to the five probe stimulation were changed significantly (P : 0.02) more than the one probe measurement. (TABLE 4) A decrease in VAS ratings to one thermode (50ЊC, 2ЊC s
91
) was found after infusions of ketamine (racemic) and ketamine (S;) compared with baseline (P : 0.001-0.002) and placebo (P : 0.008-0.01), with no difference between drugs.
A decrease in VAS ratings to one thermodes (50ЊC, 8ЊC s
) was found after infusions of ketamine (racemic) and ketamine (S;) compared with baseline (P : 0.002-0.006) and placebo (P : 0.001-0.008), with no difference active drugs.
A similar effect of the thresholds to 2ЊC s 91 and 8ЊC s 91 was found for the drugs.
VAS RATING TO ONE THERMODE USING DIFFERENT DURATIONS (TABLE 4) The VAS rating to one thermode (50ЊC and 8ЊC s
) was compared between the session where the temperature decrease immediately after 50ЊC was reached (0 s duration), and the session where temperature was maintained at 50ЊC for 2 s (2-s duration). The VAS score of the long duration stimulus was approximately two times higher than the VAS score of the short stimulus, but the changes provoked by the drugs were not different.
When data from both drug studies were pooled, VAS of the stimuli of long duration (50Њ, 2ЊC s 91 , 2 s duration) was changed significantly (P : 0.004) more than for the stimuli of short duration (50Њ, 8ЊC s 91 threshold, 0 s duration).
HEAT SUMMATION PAIN THRESHOLD (TABLE 4) Increases in the summation threshold were found after infusion of ketamine (racemic) (P : 0.001, 2.9ЊC) and ketamine (S;) (P : 0.001, 1.9ЊC), and these increases were significant compared with placebo (P : 0.001, P : 0.001, respectively).
ELECTRICAL SUMMATION PAIN THRESHOLD (TABLE 4)
Increases in the summation threshold were found after infusion of ketamine (racemic) (P : 0.003, 1.4 mA) and ketamine (S;) (P : 0.003, 1.2 mA), and these increases were significant compared with placebo (P : 0.005). (TABLE 4) The VAS ratings to repeated, electrical stimuli were reduced by ketamine (racemic) (P : 0.002) and ketamine (S;) (P : 0.02) and these decreases were significant compared with placebo (P : 0.004-0.04).
VAS RATING TO REPEATED ELECTRICAL STIMULI
Discussion
Our study suggests that ketamine (racemic) and ketamine (S;) had potent analgesic effects compared with placebo on various pain modalities involving spatial and temporal summation aspects. No systematic differences in the analgesic effect of ketamine (racemic) and ketamine (S;) on summation were detected, indicating a potency for the (S;)-isomer of twice that of the racemic mixture. Both drugs attenuated repeated heat and electrical stimuli, pain from large areas more than pain evoked from small areas, and long duration heat stimuli more than short duration stimuli. Ketamine (racemic) prolonged the reaction time significantly more than ketamine (S;) indicating a different degree of sedation or impairment of motor performance.
KETAMINE (RACEMIC) VS KETAMINE (S;)
A dose ratio (1:2) has been found using depression of the auditory evoked potentials 18 or the hypnotic effect 19 as variables. These studies did not evaluate analgesic effects. Our study suggests that the chosen target concentration (assumed to be close to actual plasma concentrations) of ketamine (S;) of 180 ng ml 91 inhibited central summation equally as 350 ng ml 91 of ketamine (racemic). However, true potency comparisons require dose-response curves for both the racemic mixture and the (S;)-isomer. In a recent clinical study the (S;)-isomer was found to be four times more potent than the (R9)-isomer for management of postoperative orofacial pain. 16 NMDA antagonists are reported to prevent windup in a wide dynamic range of neurones as a result of long-lasting C-fibre stimulation. 12 13 20 Interestingly, these drugs do not reduce the response to short-lasting C-fibre stimulation. 12 For the management of acute pain states possibly inducing wind-up and hyperexcitability (e.g. trauma and surgical procedures), ketamine (S;) seems to be a suitable drug for further clinical study.
TEMPORAL SUMMATION
For a long time temporal summation has been considered as an important mechanism for pathophysiological pain. 6 7 We have recently shown that extradurally administered analgesics (bupivacaine) have substantially less effect on stimuli with long duration than on stimuli with short duration. 4 5 This indicated that temporal summation may be an important factor for the lack of effectiveness of such anaesthetic procedures. During general anaesthesia with isoflurane, repeated stimuli were found to be largely unaffected compared with single stimuli. 3 In this study, ketamine affected repeated stimuli and thermal stimuli of long duration similar to or more than stimuli of short duration. This was interpreted as modulation of the facilitatory mechanisms underlying central temporal summation. SPATIAL 
SUMMATION
It has been reported that spinally and extradurally administered analgesics have much less effect on stimuli covering large areas than on localized stimuli. 1 2 4 The threshold to large area stimulation was lower than that to small area stimulation, indicating the role of spatial summation as described previously. 21 The measurements from the large areas were affected to the same degree or even more by ketamine than the small areas, indicating possible reduction by ketamine of the facilitatory mechanism underlying spatial summation. The obvious, complementary efficacy profiles between traditional anaesthetic procedures and ketamine suggest a clinical advantage of combining the two synergetic effects: generalized analgesia together with inhibition of summation.
EFFECT OF KETAMINE ON HEAT AND PRESSURE THRESHOLDS
The increase in heat pain threshold in this study contrasts with the results of Anis and co-workers 22 who found that ketamine had no consistent effect on the responses of dorsal horn neurones to natural stimuli, and to human findings. 23 In the study of Kristensen, Svensson and Gordth, 23 no effect of CPP (a NMDA receptor antagonist) on the thermal pain detection threshold was detected. We have recent evidence that high intensity laser heat pulses and brief electrical (20 ms train) pulses were not affected by ketamine (racemic). 14 In this study the detection pressure threshold was increased by ketamine more than the tolerance threshold. Animal studies have indicated that the effect of ketamine is dependent on stimulus intensity. 24 From an "inhibition of temporal summation" point of view, the pressure pain thresholds to small area stimulation should be inhibited more than the thresholds to the large area as the pressure pain thresholds are largest for the small area and hence it takes more time to reach the small area thresholds. From an "inhibition of spatial summation" point of view, the pressure pain thresholds to small area stimulation should be inhibited less than the thresholds to large areas. Therefore, this suggested that ketamine should provoke the largest changes in the pressure pain detection threshold to small area, and pressure pain tolerance threshold to large areas should be affected less. This was the result as seen in table 3 (mean changes of 344 kPa vs 116 kPa; P : 0.001).
In summary, we found that both ketamine (racemic) and ketamine (S;) had a general analgesic effect, an effect on repeated stimuli, an effect on long duration stimuli and an effect on stimuli covering large areas. The (S;)-isomer was approximately twice as potent in inhibiting central summation as the racemic mixture of ketamine at the chosen target concentrations. The chosen doses had the same number of side effects, although these were minimal.
